China Grand Pharmaceutical and Healthcare Holdings is a Hong Kong-based company involved in the manufacture and sale of pharmaceutical preparations, medical devices pharmaceutical intermediates, specialized raw materials and healthcare products. The company is a subsidiary of Outwit Investments. The company has operations in Hong Kong and China.
The company's products are classified as: preparations, active pharmaceutical ingredient (APIs), steroid hormones APIs, healthcare products, and agricultural and fine chemicals.
China Grand Pharmaceutical and Healthcare's preparations products include cardiovascular medicines, ophthalmic gel and eye drops, antibacterial drugs, medicines for antibiotics, and antipyretics and analgesic. Its APIs products include amino acids, analgin and metronidazole. The company's steroid hormones APIs products consists of glucocorticoid and sex hormones. Its healthcare products comprises of taurine. The company's agricultural chemicals consists of bio-pesticides, biocides, bio-feed additives, and fine chemicals such as calcium super-phosphate and dimethyl sulfate.
The company's subsidiaries include Grand Pharmaceutical (China) Company Limited, Wuhan Grand Hoyo Company Limited, Hubei Grand Fuchi Pharmaceutical and Chemical Company Limited, Zhejiang Xianju Xianle Pharmaceutical Company Limited, Hubei Wellness Pharmaceutical Company Limited and Grand Pharmaceutical Huangshi Feiyun Company Limited.
Scope of the Report
- About the Company - Historical Details, Current Ownership Structure and basic overview of China Grand Pharmaceutical and Healthcare Holdings Limited in terms of revenue, net income, and operating income.
- Financials - Details about China Grand Pharmaceutical and Healthcare Holdings Limited listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.
- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.
- Company SWOT Analysis - Outlines China Grand Pharmaceutical and Healthcare Holdings Limited’s strengths, weaknesses, and opportunities and threats facing the company.
- Recent Developments - Showcases China Grand Pharmaceutical and Healthcare Holdings Limited’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.
- Strategic Evaluation - Provides an overview of China Grand Pharmaceutical and Healthcare Holdings Limited’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.
- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.
Key Questions Answered
- What domain does China Grand Pharmaceutical and Healthcare Holdings Limited operate and what are key points about it?
- What is the product / service portfolio of China Grand Pharmaceutical and Healthcare Holdings Limited?
- How has China Grand Pharmaceutical and Healthcare Holdings Limited performed financially from the 2013?
- How does China Grand Pharmaceutical and Healthcare Holdings Limited rank among its peers in terms of revenue and market share?
- What are China Grand Pharmaceutical and Healthcare Holdings Limited strengths and weaknesses and what opportunities and threats does it face?
- What are China Grand Pharmaceutical and Healthcare Holdings Limited’s main growth strategies and how successful has the company been at implementing them?
- What is the in-house technical capability of China Grand Pharmaceutical and Healthcare Holdings Limited? Where does it procure / outsource it?
Reasons to buy
- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own
- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost
- 12 hour delivery time fulfilling your urgent requests as per your requirement
- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics
1. About the Company
1.1 History and Basic Facts
1.2 Ownership Structure and Key Executives
1.3 Head Office
1.4 Other Locations & Subsidiaries
1.5 List of Competitors
1.6 Employee Count & Distribution
2.1 Company Type (Listed / Unlisted)
2.2 Annual Statements
2.3 Key Financial Highlights
2.4 Region-wise Breakdown
3. Product / Services
4. SWOT Analysis
4.1 SWOT Overview
5. Recent Developments
5.1 Mergers & Acquisitions
5.2 Partnerships, Collaborations & Joint Ventures
5.3 New Product Launches
5.4 Business Expansion / Divestment
6. Strategic Evaluation
6.1 Corporate Strategy
6.2 Legal Issues
6.3 Analyst Outlook
7. Technology Landscape
7.1.1 Industry Snapshot
7.1.2 IT Spend
7.1.3 Key Information Technology Trends
7.2.1 IT Overview
7.2.2 Key IT Technologies
7.2.3 Recent IT Initiatives
7.2.4 IT Outsourcing Engagements
7.2.5 Key IT Management
7.2.6 CIO/CTO Profile
- About Us
- Contact Us
Fig.1: Company Snapshot
Fig.2: Locations Listing on Map
Table.1: Ownership Structure
Table.2: List of Competitors
Table.3: Annual Statements
Table.4: Key Financial Highlights
Table.5: Region-wise Breakdown
Table.6: Product/Services Overview
Table.7: Mergers & Acquisitions
Table.8: Partnerships, Collaborations & Joint Ventures
Table.9: New Product Launches
Table.10: Business Expansion / Divestment
Table 11: IT Budgets
Table 12: Key IT Management (CIO / CTO)
Table 13: IT Deals undertaken in the past years